|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1998-12-1
|
|
pubmed:abstractText |
Food and Drug Administration regulations state that ciprofloxacin hydrochloride may cause arthropathies. For this reason, such therapy is contraindicated in the pediatric population. However, several studies in children with cystic fibrosis have found the drug to be efficacious. Our hypothesis was that ciprofloxacin treatment is justified in the case of multiresistant organisms in burn populations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0004-0010
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
133
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1247-50
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9820358-Adolescent,
pubmed-meshheading:9820358-Age Factors,
pubmed-meshheading:9820358-Anti-Infective Agents,
pubmed-meshheading:9820358-Biopsy,
pubmed-meshheading:9820358-Burns,
pubmed-meshheading:9820358-Child,
pubmed-meshheading:9820358-Child, Preschool,
pubmed-meshheading:9820358-Ciprofloxacin,
pubmed-meshheading:9820358-Cross Infection,
pubmed-meshheading:9820358-Drug Monitoring,
pubmed-meshheading:9820358-Drug Resistance, Multiple,
pubmed-meshheading:9820358-Female,
pubmed-meshheading:9820358-Humans,
pubmed-meshheading:9820358-Infant,
pubmed-meshheading:9820358-Joint Diseases,
pubmed-meshheading:9820358-Male,
pubmed-meshheading:9820358-Retrospective Studies,
pubmed-meshheading:9820358-Wound Infection
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?
|
|
pubmed:affiliation |
Department of Surgery, University of Texas Medical Branch, and Shriners Hospital for Children, Galveston, USA. jphegger@utmb.edu
|
|
pubmed:publicationType |
Journal Article
|
